You have 9 free searches left this month | for more free features.

selexipag

Showing 1 - 13 of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sarcoidosis-associated Pulmonary Hypertension Trial in Worldwide (Selexipag, Placebo)

Active, not recruiting
  • Sarcoidosis-associated Pulmonary Hypertension
  • Selexipag
  • Placebo
  • Indianapolis, Indiana
  • +38 more
Jan 31, 2023

Pulmonary Arterial Hypertension Trial (Selexipag, Riociguat, CardioMEMS pulmonary artery pressure monitor)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Selexipag
  • +3 more
  • (no location specified)
Apr 11, 2023

Pulmonary Hypertension, Schistosomiasis Trial in São Paulo (Selexipag)

Unknown status
  • Pulmonary Hypertension
  • Schistosomiasis
  • Selexipag
  • São Paulo, SP, Brazil
    Universidade de São Paulo
Oct 8, 2020

Pulmonary Arterial Hypertension Trial in Worldwide (Selexipag, Placebo)

Completed
  • Pulmonary Arterial Hypertension
  • Selexipag
  • Placebo
  • Torrance, California
  • +38 more
Feb 4, 2021

Pulmonary Arterial Hypertension Trial in Worldwide (Macitentan, Tadalafil, Selexipag)

Completed
  • Pulmonary Arterial Hypertension
  • Phoenix, Arizona
  • +57 more
Mar 22, 2021

Healthy Subjects Trial in Merksem (Selexipag, Clopidogrel)

Completed
  • Healthy Subjects
  • Merksem, Belgium
    Clinical Pharmacology Unit (CPU)
May 31, 2018

Pulmonary Arterial Hypertension Trial in United States (Selexipag)

Completed
  • Pulmonary Arterial Hypertension
  • Selexipag
  • La Jolla, California
  • +14 more
Dec 28, 2017

Pulmonary Arterial Hypertension Trial in Worldwide (Selexipag, Placebo)

Completed
  • Pulmonary Arterial Hypertension
  • Selexipag
  • Placebo
  • Mobile, Alabama
  • +181 more
Dec 13, 2017

Healthy Subjects Trial in Gieres (Midazolam, Selexipag)

Completed
  • Healthy Subjects
  • Gieres, France
    Investigator Site
Oct 12, 2016

Healthy Subjects Trial in Kiel (Selexipag, Gemfibrozil, Rifampicin)

Completed
  • Healthy Subjects
  • Selexipag
  • +2 more
  • Kiel, Germany
    Investigator Site
Jul 20, 2016

Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in France, Germany, United Kingdom (Selexipag, Placebo)

Completed
  • Raynaud's Phenomenon Secondary to Systemic Sclerosis
  • Selexipag
  • Placebo
  • Grenoble cedex, France
  • +15 more
May 9, 2016

Cardiodynamics, Safety, Tolerability Trial in Evansville (selexipag, for selexipag, moxifloxacin)

Completed
  • Cardiodynamics
  • +3 more
  • selexipag
  • +3 more
  • Evansville, Indiana
    Covance Clinical Research Unit
Jul 30, 2014

Bioequivalence Trial in Groningen (selexipag)

Completed
  • Bioequivalence
  • selexipag
  • Groningen, Netherlands
    QPS
Jul 30, 2014